Lupin Foundation bags CRISIL Highest VO 1A Rating

Written By :  Ruchika Sharma
Published On 2025-11-28 07:00 GMT   |   Update On 2025-11-28 07:00 GMT
Advertisement

Mumbai: Lupin Human Welfare and Research Foundation (LHWRF), the Corporate Social Responsibility (CSR) arm of global pharma major Lupin Limited, has been awarded the CRISIL Voluntary Organisation grading of VO 1A, the highest classification, indicating ‘Very Strong Delivery Capability and High Financial Proficiency.’

For over 37 years, LHWRF has spearheaded initiatives to improve lives and livelihoods and strengthen healthcare for underserved populations across India. 

Advertisement

“We are honored to receive the VO 1A rating from CRISIL, reflecting our commitment to social welfare and sustainable growth,” said Tushara Shankar, Head – CSR, Lupin. “This recognition inspires us to expand our innovative programs that support communities and create lasting positive impact.”

Read also: Lupin Launches Strategic Partnership to Expand PrecisionSphere Long-Acting Injectable Platform

The CRISIL VO grading is a comprehensive assessment framework that evaluates an organization’s overall ability to deliver on its goals. It focuses on factors such as stakeholder engagement, system and process efficiency, implementation and monitoring mechanisms, and financial management skills, including revenue and expenditure control, resource diversification, liquidity, and transparency reporting.

Lupin Human Welfare & Research Foundation (LHWRF) is the social responsibility arm of Lupin Limited, founded by Dr Desh Bandhu Gupta in 1988. Over the past three decades, the Foundation has impacted more than 2.02 million beneficiaries across 5,400 villages in 26 districts spread across eight states in India.

Read also: Lupin Launches Strategic Partnership to Expand PrecisionSphere Long-Acting Injectable Platform

Throughout its journey, the Foundation has primarily focused on creating sustainable livelihood opportunities and fostering economic growth in some of the most underdeveloped districts in the country. 

The Livelihoods Program, a key driver of the company's development efforts over the last decade, enhances community well-being and healthcare access by strengthening health systems to effectively address non-communicable diseases such as COPD, CVD, asthma, diabetes, and hypertension.

Read also: Lupin Bioresearch Center gets zero USFDA observation after successful inspection, assessment

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News